Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
Sha Zhou(Beijing Normal University), W-B Ou(Brigham and Women's Hospital), Fanyue Meng(Zhejiang University of Technology), Ye Kuang(Kunming Medical University), Si Shi(First Affiliated Hospital of Guangzhou Medical University), Grant Eilers(Brigham and Women's Hospital), Lu Liu(Weifang Medical University), H. Li(South China Normal University), Joseph M. Corson, Jonathan A. Fletcher(Harvard University), Hua Zhou(First Affiliated Hospital Zhejiang University), X Li(Zhejiang University of Technology), Qing Sheng(Zhejiang Sci-Tech University)
Cited by 93
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
|Molecular Cancer|2021|2.2k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647